Drugs For Erectile Dysfunction Market Report 2023

Drugs For Erectile Dysfunction Global Market Report 2023 – By Drugs (Sildenafil Citrate, Mirodenafil , Vardenafil), By Mode of Administration (Oral, Topical, Injections), By End Users (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : January 2023 | Delivery Time: 2-3 business days | Format :

Need assistance or more information before the purchase?

Enquire Before Buying
Drugs For Erectile Dysfunction Market

Proud Members Of

The erectile dysfunction (ED) drugs refer to the drugs that are used to improve the effects of nitric oxide, a substance your body naturally generates that relaxes penile muscles, to treat erectile dysfunction. Erectile dysfunction is the inability to achieve or keep up a penile erection in men.

The different types of drugs in erectile dysfunction (ED) drugs are sildenafil citrate, mirodenafil, and vardenafil. Sildenafil is a drug that is used to treat erectile dysfunction and pulmonary arterial hypertension. It is offered under the trade names Viagra and others. It’s unknown whether it’s effective in treating female genital dysfunction. The different routes of administration include Oral, topical, and injections and are used by hospital pharmacies, retail pharmacies, and online pharmacies.

The global drugs for erectile dysfunction market is segmented -

1) By Drugs: Sildenafil Citrate, Mirodenafil, Vardenafil

2) By End users: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Mode of Administration: Oral, Topical, Injections

The global drugs for erectile dysfunction market size will grow from $3.21 billion in 2022 to $3.25 billion in 2023 at a compound annual growth rate (CAGR) of 1.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global drugs for erectile dysfunction market size is expected to grow to $3.36 billion in 2027 at a CAGR of 0.8%.

The drastic increase in the number of chronic diseases drives the erectile dysfunction drug market. Erectile dysfunction is mainly caused by chronic diseases resulting from a sedentary lifestyle such as cardiovascular diseases, diabetes, obesity, and high blood pressure. According to WHO, the prevalence of chronic diseases is expected to grow by 57% by the end of the year 2020. Prevalence of chronic diseases increases the chances of erectile dysfunction among men, thereby driving the erectile dysfunction drug market.

Major players in the erectile dysfunction (ED) drugs market are Eli Lilly and Co., Pfizer, Bayer AG, Dong-A Pharmaceutical Co. Ltd., Vivus, Meda Pharmaceuticals, Apricus Biosciences, Cristália, S.K. Chemicals Co and Teva Pharmaceutical Industries Ltd.

Patients suffering from erectile dysfunction do not seek treatment owing to factors such as lack of education, lack of awareness, strong religious beliefs, social taboo, and low socioeconomic status. These factors are responsible for the patients suffering from erectile dysfunction rejecting or avoiding the treatment. For example, according to a survey conducted by Opinium Research in February 2020, just 27% out of the total 2,006 men surveyed were aware that erectile dysfunction could be linked to high blood pressure or elevated cholesterol while just 22% of men surveyed were aware that erectile dysfunction is often associated with diabetes. These factors restrain the growth of the erectile dysfunction drug market.

New drug delivery techniques such as the use of pellets and creams are being implemented by many companies in the erectile dysfunction drugs market. Pellets and creams will have more efficacy and performance in erectile dysfunction and these are also more effective and safer to use. These benefits from drug delivery techniques will increase the scope of the erectile dysfunction drug market. For example, In September 2022, Lupin, an India-based pharmaceutical company launched Sildenafil for oral suspension, 10 mg/mL with the approval of the United States Food and Drug Administration (FDA). This drug is for erectile dysfunction with unique dosages.

Medicines are authorized by regulatory bodies based on quality, safety, and efficacy to make sure that medicines are of standard quality and gives positive benefit. Companies are mandated to submit the documentation for the standard quality before applying for authorization. The safety and efficacy of medicines should be demonstrated by clinical trials for all new medicines by the companies. Competent authorities will assess this data before authorizing the drugs. In Europe, the European Medicines Agency (EMA) assesses the drugs for centrally authorized products.

North America was the largest region in the erectile dysfunction (ED) drugs market in 2022. Middle East is expected to be the fastest-growing region in the global drugs for erectile dysfunction market during the forecast period. The regions covered in the global erectile dysfunction (ED) drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the erectile dysfunction (ED) drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The erectile dysfunction (ED) drugs market consists of sales Sildenafil (Viagra), vardenafil (Levitra, Staxyn), tadalafil (Cialis) and avanafil (Stendra). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The erectile dysfunction (ED) drugs market research report is one of a series of new reports from The Business Research Company that provides erectile dysfunction (ED) drugs market statistics, including erectile dysfunction (ED) drugs industry global market size, regional shares, competitors with erectile dysfunction (ED) drugs market share, detailed erectile dysfunction (ED) drugs market segments, market trends and opportunities, and any further data you may need to thrive in the erectile dysfunction (ED) drugs industry. This erectile dysfunction (ED) drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Drugs For Erectile Dysfunction Market Characteristics

    3. Drugs For Erectile Dysfunction Market Trends And Strategies

    4. Drugs For Erectile Dysfunction Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Drugs For Erectile Dysfunction Market

    4.2 Ukraine-Russia War Impact On Drugs For Erectile Dysfunction Market

    4.3 Impact Of High Inflation On Drugs For Erectile Dysfunction Market

    5. Drugs For Erectile Dysfunction Market Size And Growth

    5.1. Global Drugs For Erectile Dysfunction Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Drugs For Erectile Dysfunction Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Drugs For Erectile Dysfunction Market Segmentation

    6.1. Global Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Sildenafil Citrate

    Mirodenafil

    Vardenafil

    6.2. Global Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    6.3. Global Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Oral

    Topical

    Injections

    7. Drugs For Erectile Dysfunction Market Regional And Country Analysis

    7.1. Global Drugs For Erectile Dysfunction Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Drugs For Erectile Dysfunction Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Drugs For Erectile Dysfunction Market

    8.1. Asia-Pacific Drugs For Erectile Dysfunction Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Drugs For Erectile Dysfunction Market

    9.1. China Drugs For Erectile Dysfunction Market Overview

    9.2. China Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Drugs For Erectile Dysfunction Market

    10.1. India Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Drugs For Erectile Dysfunction Market

    11.1. Japan Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Drugs For Erectile Dysfunction Market

    12.1. Australia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Drugs For Erectile Dysfunction Market

    13.1. Indonesia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Drugs For Erectile Dysfunction Market

    14.1. South Korea Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Drugs For Erectile Dysfunction Market

    15.1. Western Europe Drugs For Erectile Dysfunction Market Overview

    15.2. Western Europe Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Drugs For Erectile Dysfunction Market

    16.1. UK Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Drugs For Erectile Dysfunction Market

    17.1. Germany Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Drugs For Erectile Dysfunction Market

    18.4. France Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Drugs For Erectile Dysfunction Market

    19.1. Eastern Europe Drugs For Erectile Dysfunction Market Overview

    19.2. Eastern Europe Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Drugs For Erectile Dysfunction Market

    20.1. Russia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Drugs For Erectile Dysfunction Market

    21.1. North America Drugs For Erectile Dysfunction Market Overview

    21.2. North America Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Drugs For Erectile Dysfunction Market

    22.1. USA Drugs For Erectile Dysfunction Market Overview

    22.2. USA Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Drugs For Erectile Dysfunction Market

    23.1. South America Drugs For Erectile Dysfunction Market Overview

    23.2. South America Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Drugs For Erectile Dysfunction Market

    24.1. Brazil Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Drugs For Erectile Dysfunction Market

    25.1. Middle East Drugs For Erectile Dysfunction Market Overview

    25.2. Middle East Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Drugs For Erectile Dysfunction Market

    26.1. Africa Drugs For Erectile Dysfunction Market Overview

    26.2. Africa Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Drugs For Erectile Dysfunction Market Competitive Landscape And Company Profiles

    27.1. Drugs For Erectile Dysfunction Market Competitive Landscape

    27.2. Drugs For Erectile Dysfunction Market Company Profiles

    27.2.1. Eli Lilly and Co.

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Pfizer

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Bayer AG

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Dong-A Pharmaceutical Co. Ltd

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Vivus

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Drugs For Erectile Dysfunction Pipeline Analysis

    29. Key Mergers And Acquisitions In The Drugs For Erectile Dysfunction Market

    30. Drugs For Erectile Dysfunction Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Historic And Forecast Inflation Rates

    31.4. Research Inquiries

    31.5. The Business Research Company

    31.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Drugs For Erectile Dysfunction Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Drugs For Erectile Dysfunction Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Eli Lilly and Co. Financial Performance
  • Table 47: Pfizer Financial Performance
  • Table 48: Bayer AG Financial Performance
  • Table 49: Dong-A Pharmaceutical Co. Ltd Financial Performance
  • Table 50: Vivus Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Drugs For Erectile Dysfunction Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Drugs For Erectile Dysfunction Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Eli Lilly and Co. Financial Performance
  • Figure 47: Pfizer Financial Performance
  • Figure 48: Bayer AG Financial Performance
  • Figure 49: Dong-A Pharmaceutical Co. Ltd Financial Performance
  • Figure 50: Vivus Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report